IR-820 (New Indocyanine Green): Precision in Near-Infrared Imaging

Executive Summary: IR-820 (New Indocyanine Green) is a high-performance near-infrared (NIR) dye with a molecular weight of 849.47, used primarily as a vascular and tumor imaging agent in live animal studies (APExBIO product page). Its strong NIR absorption and fluorescence facilitate the quantitative detection of diseased tissues, surpassing traditional dyes in sensitivity and stability (cy5-azide.com). The compound is stable as a solid at 4°C and must be used promptly after solution preparation. Recent innovations leverage IR-820 in multifunctional nanoplatforms, enabling synergistic photothermal and immunotherapy approaches (Hao et al., 2023).

Biological Rationale

Near-infrared fluorescence imaging is a cornerstone technique in preclinical research, enabling non-invasive visualization of biological processes in small animals. IR-820 (New Indocyanine Green), developed and distributed by APExBIO, is engineered to exploit the optical window of 700–900 nm, where tissue autofluorescence is low and photon penetration is high (APExBIO). This spectral property allows for deep tissue imaging with minimal background interference. The dye's strong absorption and emission in the NIR region make it suitable for quantifying vascular integrity, mapping tumor margins, and tracking tissue biodistribution (th287.com). Such quantification is critical for evaluating disease progression and therapy response in vivo.

Mechanism of Action of IR-820 (New Indocyanine Green)

IR-820 is a tricarbocyanine dye with a chemical formula of C46H50ClN2NaO6S2. It functions as a blood pool contrast agent by binding to plasma proteins, thereby remaining predominantly within the vasculature upon intravenous administration. The dye exhibits maximal absorption and emission in the near-infrared region (approximately 820 nm), enabling high-contrast imaging of blood vessels and tumor tissues due to their increased permeability and retention of NIR dyes (product information). In preclinical models, IR-820 is excited by NIR laser sources, and its fluorescence is captured by specialized detectors, permitting real-time tissue quantification (cy5-azide.com). Moreover, when incorporated into nanocarriers, IR-820 can serve as a photothermal agent, converting absorbed NIR light into localized heat for targeted ablation of tumor cells (Hao et al., 2023).

Evidence & Benchmarks

• IR-820 provides strong NIR fluorescence with peak excitation/emission near 820 nm, allowing imaging through several millimeters of biological tissue (cy5-azide.com).
• The molecular weight of IR-820 is 849.47, and it exhibits high in vivo stability when stored as a desiccated solid at 4°C (APExBIO product information).
• When used in glutathione-responsive MOF nanoparticles, indocyanine green analogues like IR-820 enable both photothermal tumor ablation and immunotherapeutic activation under 808 nm NIR irradiation (Hao et al., 2023).
• Compared to traditional dyes, IR-820 demonstrates superior signal-to-background ratios for vascular and tumor imaging in live animal models, facilitating quantitative assessment of diseased tissues (dznep.com).

Applications, Limits & Misconceptions

IR-820 is widely used as a vascular imaging agent and tumor imaging dye in biomedical research. Its primary applications include:

• Non-invasive quantification of diseased tissue in live animal models (th287.com).
• Mapping vascular and tumor distribution via NIR fluorescence imaging (cy5-azide.com).
• Integration into nanoplatforms for synergistic photothermal-immunotherapy in cancer research (Hao et al., 2023).

Despite its versatility, IR-820 has defined boundaries:

Common Pitfalls or Misconceptions

• Not for diagnostic or clinical medical use: IR-820 is validated for preclinical research only and is not approved for human diagnostic procedures (APExBIO).
• Loss of fluorescence in aqueous solution: IR-820 solutions degrade quickly; prepared solutions should be used immediately to avoid signal loss.
• Potential for misinterpretation due to autofluorescence: Although NIR minimizes background, some tissues may still exhibit residual fluorescence, necessitating appropriate controls (dznep.com).
• Inadequate tissue penetration in large animals: While effective in rodents, penetration depth and resolution decrease in larger models.
• Batch variability in photothermal applications: When used in nanoplatforms, batch-to-batch consistency must be confirmed to ensure reproducible heating and immune activation (Hao et al., 2023).

This article extends previous coverage by detailing the integration of IR-820 in advanced nanoplatforms for synergistic imaging and therapy (see workflow guide), contrasting with earlier focus on standalone imaging protocols. For molecular insights, compare with the foundational analysis in Molecular Basis & Imaging Utility, which this article updates by including recent advances in tumor immunotherapy applications.

Workflow Integration & Parameters

Protocol Parameters

• Storage: Store IR-820 as a solid at 4°C, tightly sealed and desiccated; avoid long-term storage of prepared solutions (APExBIO).
• Dilution: Prepare solutions in sterile PBS or saline immediately before use; typical working concentrations range from 0.1–1 mg/mL for small animal imaging (cy5-azide.com).
• Imaging: Excite at 780–820 nm; collect emission at 820–850 nm for optimal signal-to-noise.
• Animal dosing: For mice, doses of 1–5 mg/kg body weight are typical; inject intravenously for vascular/tumor imaging (dznep.com).
• Nanoplatform usage: For photothermal-immunotherapy studies, load IR-820 into MOF nanoparticles as per optimized protocols in Hao et al., 2023 (DOI); irradiate with 808 nm NIR laser for 5–10 minutes per session.

Conclusion & Outlook

IR-820 (New Indocyanine Green) is a validated agent for near-infrared fluorescence imaging, supporting precise in vivo quantification of vascular and tumor tissues. The integration of IR-820 into multifunctional nanoplatforms marks a significant advance, enabling not only imaging but also photothermal ablation and immune activation, as demonstrated in recent melanoma models (Hao et al., 2023). As preclinical imaging technologies evolve, IR-820 is poised to remain a gold standard for high-sensitivity, reproducible quantification in experimental research, provided its usage remains within validated boundaries and protocols.